Labcorp, a global leader of innovative and comprehensive laboratory services, and the National Association of Community Health Centers (NACHC) announced a strategic alliance to strengthen leadership development, support practice improvement and advance community health initiatives across the nation's Community Health …
Piramal Pharma Ltd. has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited, a Hyderabad-based CDMO specializing in vaccines and biologics for an aggregate cash consideration of ₹76 crore INR, or $7.95M USD. As a result of this transaction, PPL now owns 74% of Yapan Bio's equity, maki…
Shanghai Henlius Biotech announced that it has entered into a strategic collaboration with Sandoz, a global leader in generics and biosimilars, covering up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar products or components developed by Henlius. The parties have also signed …
IASO Biotechnology announced the completion of its acquisition of MediSix Therapeutics, a Singapore-based immune cell engineering and cell therapy company. This acquisition marks a step in IASO Bio's globalization strategy, integrating MediSix's differentiated T-cell engineering platform, R&D pipeline, and intern…
Atrium Therapeutics, Inc., a biopharmaceutical company dedicated to delivering RNA therapeutics to the heart, announced it has earned another $15 million milestone payment from Bristol Myers Squibb based on the successful delivery of a lead compound targeting an undisclosed cardiology indication under the Company's on…
Xcellon Biologics, a U.S.-based Contract Research, Development and Manufacturing Organization (CRDMO) specializing in bioconjugates and complex biologics, announced that it has signed a definitive agreement to acquire the GMP biologics manufacturing facility from NextCure, Inc. The acquisition marks a transformational…
Thermo Fisher Scientific Inc, the world leader in serving science, announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business…
Jazz Pharmaceuticals plc and Actio Biosciences, Inc. announced the companies have entered into a definitive agreement for Jazz to acquire privately-held Actio Biosciences for $820 million upfront and up to $500 million in contingent consideration. Actio Biosciences' lead clinical asset is ABS-1230, a novel, first-in-…
Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, has entered into a collaboration and option agreement with Ono Pharmaceutical Co., Ltd. for novel treatments targeting fibro-inflammatory diseases. These diseases are characterized by myo…
Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced that it has entered into a non-binding Memorandum of Understanding (MOU) with the Saudi Pharmaceutical Industries and Medical Appliance Company (SPIMACO) for a collaboration to bring the…
Page 3 of 40